The Complex Hospital Generics (CHG) business was volatile due to COVID in 3QFY21. On the other hand, the Contract Dev. and Manufacturing Org. (CDMO; led by a strong order book) / India Consumer business (led by increased demand for Self-Care and Baby Care products) has been steady. As the Carlyle deal commenced in Oct'20, the consol. networth jumped from INR315b to INR355b QoQ. The equity infusion was used to primarily pare down debt consol. net debt/equity ratio is at a multi-year low of 0.9x. After a lackluster 1HFY21, the Real Estate segment rebounded in 3QFY21...